Rankings
▼
Calendar
IDXX FY 2020 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena
IDXX
IDEXX Laboratories, Inc.
$48B
FY 2020 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$2.7B
+12.5% YoY
Gross Profit
$1.6B
58.0% margin
Operating Income
$695M
25.7% margin
Net Income
$582M
21.5% margin
EPS (Diluted)
$6.71
Cash Flow
Operating Cash Flow
$648M
Free Cash Flow
$540M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$2.3B
Total Liabilities
$1.7B
Stockholders' Equity
$632M
Cash & Equivalents
$384M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.7B
$2.4B
+12.5%
Gross Profit
$1.6B
$1.4B
+15.0%
Operating Income
$695M
$553M
+25.6%
Net Income
$582M
$428M
+36.0%
← Q4 2019
All Quarters
Q1 2020 →